BIOABIOANASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+31.0%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
+31.0%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
2.3x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$68.69M+16.4%
2024$59.04M+74.2%
2023$33.89M+11.0%
2022$30.52M-